EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

6-Gingerol ameliorates alveolar hypercoagulation and fibrinolytic inhibition in LPS-provoked ARDS via RUNX1/NF-κB signaling pathway

Qing Li, Chuan Xiao, JiaRun Gu, Xianjun Chen, Jia Yuan, Shuwen Li, Wei Li, Daixiu Gao, Lu Li, Ying Liu, Feng Shen

International Immunopharmacology · 2024

DOI: 10.1016/j.intimp.2023.111459 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Qing Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Unit, the Affiliated Hospital of Guizhou Medical University, Guiyang, China. Electronic address: 2538853252@qq.com. Hauptthemen laut MEDLINE: Lung Injury, Pulmonary Edema, Respiratory Distress Syndrome, Catechols. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Alveolar hypercoagulation and fibrinolytic inhibition play a central role in refractory hypoxemia in acute respiratory distress syndrome (ARDS), but it lacks effective drugs for prevention and treatment of this pathophysiology. Our previous experiment confirmed that RUNX1 promoted alveolar hypercoagulation and fibrinolytic inhibition through NF-κB pathway. Other studies demonstrated that 6-gingerol regulated inflammation and metabolism by inhibiting the NF-κB signaling pathway. We assume that 6-gingerol would ameliorate alveolar hypercoagulation and fibrinolytic inhibition via RUNX1/ NF-κB pathway in LPS-induced ARDS. METHODS: Rat ARDS model was replicated through LPS inhalation. Before LPS inhalation, the rats were intraperitoneally treated with different doses of 6-gingerol or the same volume of normal saline (NS) for 12 h, and then intratracheal inhalation of LPS for 24 h. In cell experiment, alveolar epithelial cell type II (AECII) was treated with 6-gingerol for 6 h and then with LPS for another 24 h. RUNX1 gene was down-regulated both in pulmonary tissue and in cells. Tissue factor (TF), plasminogen Activator Inhibitor 1(PAI-1) and thrombin were determined by Wester-blot (WB), qPCR or by enzyme-linked immunosorbent (ELISA). Lung injury score, pulmonary edema and pulmonary collagen III in rat were assessed. NF-κB pathway were also observed in vivo and in vitro. The direct binding capability of 6-gingerol to RUNX1 was confirmed by using Drug Affinity Responsive Target Stability test (DARTS). RESULTS: 6-gingerol dose-dependently attenuated LPS-induced lung injury and pulmonary edema. LPS administration caused excessive TF and PAI-1 expression both in pulmonary tissue and in AECII cell and a large amount of TF, PAI-1 and thrombin in bronchial alveolar lavage fluid (BALF), which all were effectively decreased by 6-gingerol treatment in a dose-dependent manner. The high collagen Ⅲ level in lung tissue provoked by LPS was significantly abated by 6-gingerol. 6-gingerol was seen to dramatically inhibit the LPS-stimulated activation of NF-κB pathway, indicated by decreases of p-p65/total p65, p-IKKβ/total IKKβ, and also to suppress the RUNX1 expression. RUNX1 gene knock down or RUNX1 inhibitor Ro5-3335 significantly enhanced the efficacies of 6-gingerol in vivo and in vitro, but RUNX1 over expression remarkably impaired the effects of 6-gingerol on TF, PAI-1 and on NF-κB pathway. DARTS result showed that 6-gingerol directly bond to RUNX1 molecules. CONCLUSIONS: Our experimental data demonstrated that 6-gingerol ameliorates alveolar hypercoagulation and fibrinolytic inhibition via RUNX1/NF-κB pathway in LPS-induced ARDS. 6-gingerol is expected to be an effective drug in ARDS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung InjuryPulmonary EdemaRespiratory Distress SyndromeCatecholsFatty AlcoholsRatsAnimalsNF-kappa BLipopolysaccharidesPlasminogen Activator Inhibitor 1Core Binding Factor Alpha 2 SubunitI-kappa B KinaseThrombinSignal TransductionCollagen

Stichwörter der Autor:innen

6-GingerolAcute respiratory distress syndromeAlveolar hypercoagulationFibrinolytic inhibitionNF-κB signaling pathwayRunt-related transcription factor 1

Substanzen

NF-kappa BLipopolysaccharidesgingerolPlasminogen Activator Inhibitor 1Core Binding Factor Alpha 2 SubunitI-kappa B KinaseThrombinCollagenCatecholsFatty Alcohols

Autor:innen und Institutionen

  • Department of Intensive Care Unit, the Affiliated Hospital of Guizhou Medical University, Guiyang, China. Electronic address: 2538853252@qq.com.
  • Department of Intensive Care Unit, the Affiliated Hospital of Guizhou Medical University, Guiyang, China. Electronic address: xc15973986196@163.com.
  • Emergency department, the Affiliated Hospital of Guizhou Medical University, Guiyang, China. Electronic address: dr_gujiarun@163.com.
  • Department of Intensive Care Unit, the Affiliated Hospital of Guizhou Medical University, Guiyang, China. Electronic address: 625523909@qq.com.
  • Department of Intensive Care Unit, the Affiliated Hospital of Guizhou Medical University, Guiyang, China. Electronic address: 1006783013@qq.com.
  • Department of Intensive Care Unit, the Affiliated Hospital of Guizhou Medical University, Guiyang, China. Electronic address: 382574528@qq.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Li, Q., Xiao, C., Gu, J., Chen, X., Yuan, J., Li, S., Li, W., Gao, D., Li, L., Liu, Y., & Shen, F. (2024). 6-Gingerol ameliorates alveolar hypercoagulation and fibrinolytic inhibition in LPS-provoked ARDS via RUNX1/NF-κB signaling pathway. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.111459

Vancouver

Li Q, Xiao C, Gu J, Chen X, Yuan J, Li S, et al. 6-Gingerol ameliorates alveolar hypercoagulation and fibrinolytic inhibition in LPS-provoked ARDS via RUNX1/NF-κB signaling pathway. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2023.111459

BibTeX
@article{Li2024,
  author = {Li, Qing and Xiao, Chuan and Gu, JiaRun and Chen, Xianjun and Yuan, Jia and Li, Shuwen and Li, Wei and Gao, Daixiu and Li, Lu and Liu, Ying and Shen, Feng},
  title = {6-Gingerol ameliorates alveolar hypercoagulation and fibrinolytic inhibition in LPS-provoked ARDS via RUNX1/NF-κB signaling pathway},
  journal = {International Immunopharmacology},
  year = {2024},
  doi = {10.1016/j.intimp.2023.111459}
}
Kostenlos starten →